Business Context and Reporting Period
This Form 8-K was filed by Amedica Corporation on December 30, 2015. The report discloses a material event under Item 8.01 (Other Events) regarding a new strategic partnership. Note: The request metadata references "Sintx Technologies, Inc.," but the filing text explicitly identifies the registrant as Amedica Corporation.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures for the reporting period.
Material Changes
The primary material change disclosed is the execution of a private label supply agreement with BoTEC Medical, a subsidiary of WinnTi Medical Group. Key details include:
- Partner Profile: BoTEC Medical is described as one of the fastest-growing orthopedic companies in the People's Republic of China, focusing on extremity and spine solutions.
- Strategic Impact: The agreement establishes a long-term collaborative partnership between Amedica Corporation and BoTEC Medical.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, quantitative outlook projections, or a detailed discussion of risks and contingencies. The management commentary is limited to the announcement of the partnership and the inclusion of the press release as Exhibit 99.1.
Investor Verification Checklist
- Verify the terms and financial implications of the private label supply agreement with BoTEC Medical in the attached press release (Exhibit 99.1).
- Confirm the strategic fit of the partnership with Amedica's existing product portfolio in extremity and spine solutions.
- Review subsequent filings for any revenue recognition or financial impact resulting from this agreement.